JSJing Shi

Jing Shi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jing Shi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Hui Wang

    Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

    2 shared publications
  • Xiangqing Kong

    Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

    2 shared publications
  • Beibei Li

    Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

    1 shared publication
  • Hui Liu

    Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

    1 shared publication
  • Qiulian Zhou

    Cardiac Regeneration and Ageing Lab, School of Life Science, Shanghai University, Shanghai 200444, China

    1 shared publication
  • Yihua Bei

    Institute of Geriatrics (Shanghai University), Affiliated Nantong Hospital of Shanghai University (The Sixth People’s Hospital of Nantong) and School of Life Sciences, Shanghai University, Nantong, China

    1 shared publication

Latest Publications

  • Open Access

    MicroRNA Expression Signature in Human Calcific Aortic Valve Disease

    by Hui Wang, Jing Shi, Beibei Li, Qiulian Zhou, Xiangqing Kong, Yihua Bei

    Altered microRNA (miRNA, miR) expression has been related to many disease processes; however, the miRNA expression signature in calcific aortic valve disease (CAVD) is unclear. In this study, microarrays were used to determine the miRNA expression signature of tissue samples from healthy individuals (n=4) and patients with CAVD (n=4). TargetScan, PITA, and microRNAorg 3-way databases were used to predict the potential target genes. DIANA-miRPath was used to incorporate the aberrant miRNAs into gene pathways. miRNA microarrays identified 92 differentially expressed miRNAs in CAVD tissues. The principal component analysis (PCA) of these samples and the unsupervised hierarchical clustering analysis based on the 92 aberrantly expressed miRNAs noted that miRNA expression could be categorized into two well-defined clusters that corresponded to healthy control and CAVD. Bioinformatic analysis showed the miRNA targets and potential molecular pathways. Collectively, our study reported the miRNA expression signature in CAVD and may provide potential therapeutic targets for CAVD.


  • Open Access

    MicroRNA Expression Signature in Degenerative Aortic Stenosis

    by Jing Shi, Hui Liu, Hui Wang, Xiangqing Kong

    Degenerative aortic stenosis, characterized by narrowing of the exit of the left ventricle of the heart, has become the most common valvular heart disease in the elderly. The aim of this study was to investigate the microRNA (miRNA) signature in degenerative AS. Through microarray analysis, we identified the miRNA expression signature in the tissue samples from healthy individuals (n=4) and patients with degenerative AS (n=4). Six miRNAs (hsa-miR-193a-3p, hsa-miR-29b-1-5p, hsa-miR-505-5p, hsa-miR-194-5p, hsa-miR-99b-3p, and hsa-miR-200b-3p) were overexpressed and 14 (hsa-miR-3663-3p, hsa-miR-513a-5p, hsa-miR-146b-5p, hsa-miR-1972, hsa-miR-718, hsa-miR-3138, hsa-miR-21-5p, hsa-miR-630, hsa-miR-575, hsa-miR-301a-3p, hsa-miR-636, hsa-miR-34a-3p, hsa-miR-21-3p, and hsa-miR-516a-5p) were downregulated in aortic tissue from AS patients. GeneSpring 13.1 was used to identify potential human miRNA target genes by comparing a 3-way comparison of predictions from TargetScan, PITA, and microRNAorg databases. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed to identify potential pathways and functional annotations associated with AS. Twenty miRNAs were significantly differentially expressed between patients with AS samples and normal controls and identified potential miRNA targets and molecular pathways associated with this morbidity. This study describes the miRNA expression signature in degenerative AS and provides an improved understanding of the molecular pathobiology of this disease.